Schering AG

From WikiMD's WELLNESSPEDIA

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin. It was founded in 1851 by Ernst Christian Friedrich Schering as Schering'sche Apotheke. The company merged with Bayer in 2006 and was renamed Bayer Schering Pharma AG.

History[edit]

Schering AG was founded in 1851 by Ernst Christian Friedrich Schering as Schering'sche Apotheke in the Mitte district of Berlin. From 1918 onwards, Schering AG operated as a public limited company, or Aktiengesellschaft in German.

In 1929, the company became the world's largest producer of hormonal preparations due to its development of the first reliable pregnancy test. Schering AG focused on the business areas of gynaecology, andrology, multiple sclerosis, oncology, and contrast agents.

In 2006, Schering AG was acquired by Bayer and was renamed Bayer Schering Pharma AG. The acquisition was one of the largest in the history of the German pharmaceutical industry.

Products[edit]

Schering AG was known for the manufacture of high-quality pharmaceutical products. Some of its well-known products included the oral contraceptive Yasmin, the multiple sclerosis drug Betaferon, and the cancer drug Nexavar.

Research and Development[edit]

Schering AG was a research-intensive pharmaceutical company. It invested heavily in research and development, with a focus on the areas of gynaecology, andrology, multiple sclerosis, oncology, and contrast agents.

Legacy[edit]

Today, the legacy of Schering AG lives on in the form of Bayer Schering Pharma AG, which continues to be a leading player in the global pharmaceutical industry.

See Also[edit]

References[edit]

External Links[edit]


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Schering AG[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Schering_AG&oldid=6347735"